News

Exciting News from the MyMeta Force Team!

June 1, 2023 | BALTIMORE –  Complete Omics’ Clinical Metablomics team are overjoyed to announce that Dr. Liang Zhao, an esteemed expert in metabolomics, proteomics, and lipidomics, with a profound focus on cancer metabolism and immuno-metabolism, has joined our MyMeta Force team as the leader. Dr. Zhao’s pioneering research involves the sophisticated application of mass spectrometry-based metabolomics and proteomics, alongside integrating molecular biology and bioinformatics, to unravel the biomedical significance of metabolites and proteins. His dedication to translating omics findings into clinical applications is notable, aiming at the development of innovative biomarkers, AI-enhanced diagnostic panels, and novel therapeutic strategies for cancer treatment.

Read more >
Read more

Exciting Feature: Complete Omics and Our Founder Qing Wang Shine on The Scientist’s Channel!

July 18, 2021 | BALTIMORE –  Complete Omics team is thrilled to announce an extraordinary milestone for Complete Omics Inc. The Scientist’s Channel, renowned for spotlighting the trailblazers at the forefront of scientific inquiry and innovation, has featured our esteemed founder, Qing Wang, in a compelling showcase that highlights the groundbreaking work we are doing here at Complete Omics.

Read more >
Read more

Collaboration with Columbia University

Mar 30, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Kam W. Leong, Samuel Y. Sheng professor of Biomedical Engineering, and his team from Columbia University on a clinical proteomics project focusing on leveraging our Complete360 quantitative proteomics assays for clinical discoveries.

Read more

Collaboration with Tel Aviv University

Mar 20, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Miguel Weil from Department of Cell Research and Immunology at the Tel Aviv University on a clinical proteomics project focusing on leveraging our Complete360 body fluid proteomics assays for clinical discoveries.

Read more

Detecting and Absolutely Quantifying Patient-specific Neoantigens from Limited Input of Biopsy Sample — An Integrated Pipeline for Neoantigen-targeted Cancer Treatments

Feb 28, 2022 | BALTIMORE –  Complete Omics Inc, a multi-omics molecular diagnostics company, today announces the publication of a new peer reviewed paper in the academic journal CANCERS, presenting a new pipeline developed for validating and absolutely quantifying neoantigens from very limited amount of clinical samples.

Read more >
Read more

Collaboration with Lisbon School of Medicine

Feb 26, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Luis Marques da Costa and his team from Lisbon School of Medicine on a clinical proteomics project focusing on leveraging our Complete360 body fluid proteomics assays for clinical discoveries.

Read more

Collaboration with University of Utah Huntsman Cancer Institute

Feb 07, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Sumati Gupta and her team from University of Utah Huntsman Cancer Institute on a clinical proteomics project focusing on leveraging our Complete360 proteomics assays for clinical discoveries.

Read more

Identifying and Quantifying Neoantigens derived from Human endogenous retroviruses (HERVs) — A new class of targets to expand the benefits of cancer immunotherapy.

Jan 29, 2022 | BALTIMORE –  Complete Omics Inc, a multi-omics molecular diagnostics company, today announces the publication of a new peer reviewed paper in Science Advances journal, demonstrating the value of targeting antigens derived from human endogenous retroviruses (HERVs) specifically overexpressed by tumor cells for new immunotherapy approaches.

Read more >
Read more

Collaboration with Baylor College of Medicine

Jan 19, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Andras Attila Heczey and his team from Baylor College of Medicine on a clinical proteomics project focusing on leveraging our Complete360 body fluid proteomics assays for clinical discoveries.

Read more

Collaboration with Washington University in St. Louis

Jan 12, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Marco Sardiello and his team from Washington University in St. Louis on a clinical proteomics project focusing on using Complete360 platform for identifying novel biological mechanisms.

Read more
Follow by Email
Facebook
Twitter
LinkedIn